Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 84, Issue 6, 2007, Pages 1825-1829

  Hsu, Po Kuei ^a   Huang, Hsu Chih ^a   Hsieh, Chih Cheng ^a   Hsu, Han Shui ^a   Wu, Yu Chung ^a   Huang, Min Hsiung ^a   Hsu, Wen Hu ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PATIENT SELECTION; PLEURA; PRIORITY JOURNAL; PROGNOSIS; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FORMALDEHYDE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE FIXATION;

EID: 36248931088     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.07.016     Document Type: Article

References (26)

1. Greene F.L., Page D.L., and Fleming I.D. Lung. American Joint Committee on Cancer (AJCC) cancer staging manual. 6th ed. (2002), Springer, New York, NY 167-178
2. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
3. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 350 (2004) 351-360
4. Strauss G.M., Herndon J., Maddaus M.A., et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) protocol 9633. Abstract 7019. J Clin Oncol 22 (2004) 621s
5. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 352 (2005) 2589-2597
6. Douillard J., Rosell R., Delena M., et al. Phase III adjuvant vinorelbine and cisplatin versus observation in completely resected (stage I-III) non-small cell lung cancer (NSCLC) patients: final results after 70 months follow-up. Abstract 7013. J Clin Oncol 23 (2005) 624s
7. Kato H., Ichinose Y., Ohta M., et al. A randomized trial of adjuvant chemotherapy with Uracil-Tegafur for adenocarcinoma of the lung. N Engl J Med 350 (2004) 1713-1721
8. Marchevsky A.M. Problems in pathologic staging of lung cancer. Arch Pathol Lab Med 130 (2006) 292-301
9. Goldstein N.S., Soman A., and Sacksner J. Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. Am J Clin Pathol 111 (1999) 349-351
10. Pritt B., Tessitore J.J., Weaver D.L., and Blaszyk H. The effect of tissue fixation and processing on breast cancer size. Hum Pathol 36 (2005) 756-760
11. Schned A.R., Wheeler K.J., Hodorowski C.A., et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 20 (1996) 1501-1506
12. Siu K.F., Cheung H.C., and Wong J. Shrinkage of the esophagus after resection for carcinoma. Ann Surg 203 (1986) 173-176
13. Prento P., and Lyon H. Commercial formalin substitutes for histolopathology. Biotech Histochem 72 (1997) 273-282
14. Werner M., Chott A., Fabiano A., and Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 24 (2000) 1016-1019
15. Schoen R.E., Gerber L.D., and Margulies C. The pathologic measurement of polyp size is preferable to the endoscopic estimate. Gastrointest Endosc 46 (1997) 492-496
16. Gopalswamy N., Shenoy V.N., Choudhry U., et al. Is in vivo measurement of size of polyps during colonoscopy accurate?. Gastrointest Endosc 46 (1997) 497-502
17. Salmhofer W., Rieger E., Soyer P., Smolle J., and Kerl H. Influence of skin tension and formalin fixation on sonographic measurement of tumor thickness. J Am Acad Dermatol 34 (1996) 34-39
18. Quester R., and Schroder R. The shrinkage of the human brain stem during formalin fixation and embedding in paraffin. J Neurosci Methods 75 (1997) 81-89
19. Rena O., Oliaro A., Cavallo A., et al. Stage I non-small cell lung carcinoma: really an early stage?. Eur J Cardiothorac Surg 21 (2002) 514-519
20. Gail M.H., Eagan R.T., Feld R., et al. Prognostic factors in patients with resected stage I non-small cell lung cancer. Cancer 54 (1984) 1802-1813
21. Christian C., Erica S., and Uliano M. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: Evidence for a two thresholds tumor diameters classification. Lung Cancer 54 (2006) 185-191
22. Pelletier M.P., Edwardes M.D., Michel R., Halwani F., and Morin J.E. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 44 (2001) 180-188
23. Pairolero P.C., Williams D.E., Bergstralh E.J., Piehler J.M., Bernatz P.E., and Payne W.S. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 38 (1984) 331-338
24. Martin-Ucar A.E., Nakas A., Pilling J.E., West K.J., and Waller D.A. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 27 (2005) 675-679
25. Jazieh A.R., Hussain M., Howington J.A., et al. Prognostic factors in patients with surgically resected stage I and II non-small cell lung cancer. Ann Thorac Surg 70 (2000) 1168-1171
26. Wertzel H., Siebert H., Lange W., Swoboda L., Graf E., and Hasse J. Results after surgery in stage I bronchogenic carcinoma. Thorac Cardiovasc Surg 46 (1998) 365-369